CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2030
Detailed information
CancerLivER ID2030
BiomarkerRCOR3-013
Biomarker Name/Symbol (given in Publication)RCOR3-013
BiomoleculeLncRNA
SubjectHuman
Degree of ValidityPotential diagnostic and prognostic biomarker for ICC metastasis and validated on independent dataset
Experimental ConditionICC v/s Normal; significantly downregulated in ICC with tumor metastasis
Cancer typeCholangiocarcinoma
RegulationDownregulated in ICC (with log fold change of more than 2)
Level of significance p < 0.05
SourceTissue
PMID28401021
Type of BiomarkerDiagnostic and Prognostic
PathwayERBB, JAK/STAT, MAPK, VEGF and WNT signaling pathways
Cohort4 paired cancerous and adjacent non-cancerous tissues in training and 32 of ICC patients and 4 of normal subjects for validation
SensitivityNA
SpecificityNA
AccuracyNA
AUCNA
DiseaseIntrahepatic cholangiocarcinoma
Year of Publication2017
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top